\begin{tabular}{lrrrrr}
\toprule
{} &                        day &                       wake &                   exercise &                   recovery &                      sleep \\
level_1                                      &                            &                            &                            &                            &                            \\
\midrule
All days (d=2115)                            &                        NaN &                        NaN &                        NaN &                        NaN &                        NaN \\
Mean glucose [mg/dL]                         &     145.3 & [135.3--157.0] &     150.4 & [138.3--160.7] &     143.6 & [130.4--163.0] &     157.3 & [141.8--165.1] &     134.9 & [126.1--143.5] \\
Glycemic variability [\%]                    &  \hl39.9 & \hl[34.0--41.7] &  \hl38.9 & \hl[33.3--40.9] &  \hl36.9 & \hl[34.9--44.3] &        35.5 & [32.7--41.9] &  \hl40.3 & \hl[36.0--46.8] \\
\hspace{7mm}hypoglycemia L2 (<54 mg/dL)      &     \hl1.3 & \hl[0.4--2.9] &           0.8 & [0.3--1.9] &           0.5 & [0.2--1.1] &           0.5 & [0.2--1.5] &     \hl2.3 & \hl[0.7--4.2] \\
\hspace{7mm}hypoglycemia L1 (54-69 mg/dL)    &     \hl4.2 & \hl[2.2--6.4] &     \hl3.5 & \hl[1.9--5.2] &     \hl3.4 & \hl[2.0--4.9] &           2.3 & [1.4--4.5] &     \hl6.2 & \hl[2.1--8.8] \\
\hspace{7mm}target range (70-180 mg/dL)      &  \hl66.1 & \hl[62.4--82.2] &  \hl66.6 & \hl[59.2--81.9] &        71.0 & [58.7--83.0] &  \hl67.2 & \hl[59.1--72.6] &        72.4 & [62.4--80.7] \\
\hspace{7mm}hyperglycemia L1 (181-250 mg/dL) &        17.9 & [12.6--22.2] &        18.7 & [13.4--23.7] &         14.5 & [9.4--26.8] &  \hl21.9 & \hl[16.1--24.1] &         13.6 & [9.2--16.5] \\
\hspace{7mm}hyperglycemia L2 (>250 mg/dL)    &     \hl7.0 & \hl[1.5--9.9] &    \hl6.9 & \hl[1.5--10.1] &    \hl8.0 & \hl[1.3--10.7] &    \hl6.5 & \hl[3.4--11.2] &           3.7 & [1.5--8.2] \\
Competition days (d=256)                     &                        NaN &                        NaN &                        NaN &                        NaN &                        NaN \\
Mean glucose [mg/dL]                         &     143.6 & [139.4--160.3] &     153.3 & [142.7--166.1] &     170.6 & [160.3--178.0] &     164.3 & [144.4--178.4] &     129.2 & [123.0--153.4] \\
Glycemic variability [\%]                    &  \hl37.5 & \hl[29.4--39.8] &  \hl36.9 & \hl[30.2--38.0] &        30.0 & [29.1--38.0] &        32.8 & [28.7--41.0] &        35.7 & [25.5--44.4] \\
\hspace{7mm}hypoglycemia L2 (<54 mg/dL)      &           0.6 & [0.3--1.7] &           0.5 & [0.3--1.4] &           0.0 & [0.0--0.2] &           0.3 & [0.0--0.8] &           0.5 & [0.0--3.5] \\
\hspace{7mm}hypoglycemia L1 (54-69 mg/dL)    &           2.4 & [1.4--4.1] &           2.2 & [0.9--3.9] &           0.5 & [0.1--1.5] &           1.6 & [0.8--3.8] &           2.9 & [0.8--8.5] \\
\hspace{7mm}target range (70-180 mg/dL)      &  \hl64.1 & \hl[60.3--84.7] &  \hl68.8 & \hl[58.2--81.5] &  \hl58.6 & \hl[56.4--68.9] &  \hl64.9 & \hl[58.2--75.7] &        73.8 & [58.0--93.1] \\
\hspace{7mm}hyperglycemia L1 (181-250 mg/dL) &        18.2 & [12.9--24.4] &        18.8 & [15.3--25.0] &  \hl23.7 & \hl[20.4--31.5] &  \hl20.8 & \hl[15.3--25.3] &         11.2 & [4.3--19.0] \\
\hspace{7mm}hyperglycemia L2 (>250 mg/dL)    &    \hl6.9 & \hl[1.2--12.1] &    \hl6.0 & \hl[1.7--12.0] &   \hl12.8 & \hl[7.0--18.2] &    \hl7.7 & \hl[2.1--14.4] &          0.5 & [0.0--13.7] \\
Training days (d=1536)                       &                        NaN &                        NaN &                        NaN &                        NaN &                        NaN \\
Mean glucose [mg/dL]                         &     141.8 & [135.6--151.1] &     146.6 & [138.2--151.9] &     137.5 & [125.6--151.4] &     154.6 & [142.9--159.8] &     133.2 & [124.9--138.5] \\
Glycemic variability [\%]                    &  \hl40.6 & \hl[33.4--42.3] &  \hl39.2 & \hl[32.8--41.0] &  \hl37.5 & \hl[35.0--44.3] &        35.6 & [32.8--40.8] &  \hl41.0 & \hl[34.9--47.1] \\
\hspace{7mm}hypoglycemia L2 (<54 mg/dL)      &     \hl1.5 & \hl[0.4--2.7] &           0.8 & [0.3--1.7] &           0.6 & [0.2--1.1] &           0.4 & [0.2--1.3] &     \hl2.9 & \hl[0.6--4.3] \\
\hspace{7mm}hypoglycemia L1 (54-69 mg/dL)    &     \hl4.8 & \hl[2.2--6.8] &     \hl4.3 & \hl[2.0--5.1] &     \hl3.4 & \hl[2.2--6.3] &           2.3 & [1.4--4.2] &     \hl6.3 & \hl[2.4--9.3] \\
\hspace{7mm}target range (70-180 mg/dL)      &  \hl67.4 & \hl[64.6--82.4] &  \hl68.5 & \hl[63.2--82.6] &        74.0 & [61.8--83.5] &  \hl68.5 & \hl[59.5--72.6] &        70.6 & [62.0--80.2] \\
\hspace{7mm}hyperglycemia L1 (181-250 mg/dL) &        16.9 & [11.6--21.2] &        18.4 & [12.3--22.6] &         14.1 & [8.5--22.7] &  \hl22.2 & \hl[16.4--23.2] &         12.4 & [9.3--16.3] \\
\hspace{7mm}hyperglycemia L2 (>250 mg/dL)    &     \hl5.7 & \hl[1.4--8.7] &     \hl6.1 & \hl[1.5--8.6] &     \hl6.7 & \hl[0.9--8.7] &     \hl6.1 & \hl[3.5--9.7] &           3.7 & [1.7--6.8] \\
\bottomrule
\end{tabular}
